Cargando…
ABVE-PC and modified BEACOPP regimen in Indian children with Hodgkin lymphoma: Feasibility and efficacy
AIMS: To study the toxicity of ABVE-PC (doxorubicin, bleomycin, vincristine, etoposide, prednisone and cyclophosphamide) and modified-BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) in intermediate-risk and high-risk Hodgkin lymphoma patients. MET...
Autores principales: | Jayabose, Somasundaram, Viswanathan, Kasi, Kumar, Vignesh, Annamalai, Annapoorani, Srinivasan, Arathi, Scott, Julius Xavier, Rathnam, Krishnakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854041/ https://www.ncbi.nlm.nih.gov/pubmed/27168709 http://dx.doi.org/10.4103/0971-5851.180142 |
Ejemplares similares
-
ABVD and BEACOPP regimens’ effects on fertility in young males with Hodgkin lymphoma
por: Amin, M. S. A., et al.
Publicado: (2020) -
P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
por: Dragičević, Ida Hude, et al.
Publicado: (2022) -
A pilot study of EVAP/ABV chemotherapy in 25 newly diagnosed children with Hodgkin's disease.
por: Ekert, H., et al.
Publicado: (1993) -
Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP
por: Jachimowicz, Ron D., et al.
Publicado: (2021) -
Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
por: Hess, Patrick P., et al.
Publicado: (2022)